Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006

Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States

Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673

Influenza-Associated Hospitalizations in the United States

Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,964

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789

The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature

Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100

The Efficacy of Influenza Vaccination in Elderly Individuals

Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 883

Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population

Simonsen, L., Reichert, T. A., Viboud, C. G., Blackwelder, W. C., Taylor, R. J., & Miller, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.265 · Cited by 541

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388

Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

Davlin, S. L., Blanton, L., Kniss, K. L., Mustaquim, D., Smith, S., Kramer, N. A., Cohen, J., Cummings, C. N., Garg, S., Flannery, B. L., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6522a3 · Cited by 328

Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

Gallo, M., Lasagna, A., Renzelli, V., Morviducci, L., Cortellini, A., Monami, M., Marino, G., Gori, S., Verzè, M., Ragni, A., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02586-5 · Cited by 3

Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review

Martins, A. M., Juan, L. F. V., Santos, M., & Martins, J. P. (2025) · Vaccines · doi:10.3390/vaccines13080859 · Cited by 3

Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy

Strowd, R. E., III, Russell, G. B., Hsu, F., Carter, A. F., Chan, M. D., Tatter, S. B., Laxton, A. W., Alexander‐Miller, M. A., High, K. P., & Lesser, G. J. (2018) · Neuro-Oncology Practice · doi:10.1093/nop/npx035 · Cited by 3

Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada

Ramjee, L., Lemay, W., Vurgun, N., Charland, N., Bauch, C. T., Pullagura, G. R., Houle, S. K. D., & Tremblay, G. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1908797 · Cited by 3

T Cell Response to Influenza Vaccination Remains Intact in Adults with Congenital Heart Disease Who Underwent Early Thymectomy

Leone, D. M., Park, H., Ünlü, S., Gurvitz, M. Z., Kang, I., & Elder, R. W. (2022) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2022.100359 · Cited by 4

Which Enhanced Influenza Vaccine Has the Greatest Immunogenicity in Long-Term Care Residents: The Adjuvanted or the High-Dose Formulation?

Didion, E. M., Kass, J. D., Wilk, D. J., Buss, E., Frischmann, S.-M., Rubeck, S., Banks, R. E., Wilson, B. M., Gravenstein, S., & Canaday, D. H. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.105625 · Cited by 3

Impfungen aus pneumologischer Sicht

Forstner, C., & Pletz, M. W. (2015) · Der Internist · doi:10.1007/s00108-015-3734-8 · Cited by 3

Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial

Volling, C., Coleman, B. L., Katz, K. C., Simor, A. E., Muller, M. P., Powis, J. E., McElhaney, J. E., & McGeer, A. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.05.002 · Cited by 3

Serological response to influenza vaccination among adults hospitalized with community‐acquired pneumonia

Pratt, C. Q., Zhu, Y., Grijalva, C. G., Wunderink, R. G., Courtney, D. M., WATERER, G. W., Levine, M. Z., Jefferson, S. N., Self, W. H., Williams, D. J., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12622 · Cited by 3

Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals

Chawansuntati, K., Chotirosniramit, N., Sugandhavesa, P., Aurpibul, L., Thetket, S., Kosashunhanan, N., Supindham, T., Kaewthip, O., Sroysuwan, P., Sirisanthana, T., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1051275 · Cited by 3

High-dose influenza vaccine in nursing home residents: not to be sneezed at

Widdowson, M., & Bresee, J. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30290-4 · Cited by 3

Vaccine Use in Immunocompromised Adults

Whitaker, J. A., Valles, K. A., Tosh, P. K., & Poland, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55435-0.00009-4 · Cited by 3

Travellers with Special Needs

Torresi, J., McGuinness, S. L., Leder, K. S., O'Brien, D. P., Ruff, T., Starr, M., & Gibney, K. B. (2019) · Springer eBooks · doi:10.1007/978-981-13-7252-0_7 · Cited by 3

Age-Specific Seasonal Influenza Vaccine Effectiveness against Different Influenza Subtypes in the Hospitalized Population in Lithuania during the 2015–2019 Influenza Seasons

Kuliešė, M., Mickienė, A., Jančorienė, L., Zablockienė, B., Gefenaitė, G., & Study Group (2021) · Vaccines · doi:10.3390/vaccines9050455 · Cited by 3

ERS International Congress 2022: highlights from the Respiratory Infections Assembly

Banka, R. A., Chichirelo-Konstantynovych, K. D., Horton, K. L., Konstantynovych, T. V., Long, M. B., McDonnell, M. J., Meldrum, O. W., Park, M., Perea, L., Viltsaniuk, O., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00628-2022 · Cited by 3

Increasing Protection of Dialysis Patients against Influenza

Lindley, M. C., & Kim, D. K. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11670918 · Cited by 3

Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality

Anderson, M., Dobkin, C., & Gorry, D. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0829 · Cited by 3

Comparing higher-dose and single standard-dose influenza vaccines in preventing cardiovascular events: a meta-analysis with 68,713 patients

Omidi, F., Rahmannia, M., Khalili, F., Bonjar, A. H. S., & Nasiri, M. J. (2024) · Public Health · doi:10.1016/j.puhe.2024.06.034 · Cited by 2

A Call for Adopting High-Dose Influenza Vaccines for Adults Aged 65 and Above in Gulf Cooperation Council (GCC) Countries

Awaidy, S. T. A., Koul, P. A., Khamis, F. A., Slil, F. A., Jroundi, I., Olama, F. A., Elawad, K. H., Abuhasan, M. Y., Oraimi, F. A., Tanrıöver, M. D., et al. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00292-8 · Cited by 2

Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine

Pareek, M., Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager‐Pedersen, M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.36889 · Cited by 2

Ageing with HIV-1: immunological challenges for effective vaccination

Saint-Charles, P., Didierlaurent, A. M., & Appay, V. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00544-6 · Cited by 2

High-dose influenza vaccine: enhanced protection for the elderly

Trombetta, C. M., & Montomoli, E. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2596673 · Cited by 2

Development of an adjuvanted, higher-dose, cell-based influenza vaccine: combining advanced technologies to improve vaccine effectiveness

Ashraf, M., Boivin, W. A., Nguyen‐Van‐Tam, J. S., Nolan, T. M., Stein, A. N., & Russell, C. A. (2026) · Expert Review of Vaccines · doi:10.1080/14760584.2026.2667732 · Cited by 2

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults

Skaarup, K. G., Lassen, M. C. H., Hosseini, K., Johansen, N. D., Loiacono, M. M., Harris, R. C., Samson, S., PALMU, A. A. I., McConeghy, K. W., Gravenstein, S., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.14620 · Cited by 2

Effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults: a systematic review and meta-analysis

Zhao, W., Lian, R., Zhao, Y., Li, Z., Liu, M., Yang, F., Zhang, J., Tian, J., Xue, F., & Gao, Y. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2026.100870 · Cited by 2

Vaccination and safe living strategies for solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Kumar, D., Avery, R. K., Danziger‐Isakov, L. A., Hall, V. G., Hanisch, B. R., Harris, C. E., Kates, O. S., Nam, H. H., Rolfe, R. J., & Kotton, C. N. (2026) · American Journal of Transplantation · doi:10.1016/j.ajt.2026.07.033 · Cited by 2

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in nursing home residents aged 65 and older in France: a nationwide cohort study on the French health data system from the 2022–2023 season

Bricout, H., LEVANT, M.-C., Crépey, P., Gavazzi, G., Gaillat, J., Dufournet, M., Assi, N., Grenier, B., RAGUIDEAU, F., Salamand, C., et al. (2026) · Age and Ageing · doi:10.1093/ageing/afag238 · Cited by 2

High-dose influenza vaccination

Dalcin, D., & Kwong, J. C. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.181477 · Cited by 2

Saisonale Influenza – Aktuelles zu Epidemiologie, Prävention und Therapie

Brehm, T. T., & Hennigs, A. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1838-9223 · Cited by 2

Inactivated and Recombinant Influenza Vaccines

Patel, M. M., Grohskopf, L. A., Sambhara, S. R., Belser, J. A., Katz, J. M., & Fry, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00033-5 · Cited by 2

Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination

Horswell, R. L., Chu, S. T., Stone, A. E., Fort, D. G., Uwaifo, G. I., Fonseca, V. A., & Norton, E. B. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003841 · Cited by 2

Effectiveness and safety of a novel intranasal influenza vaccine in Chinese children: A phase IV multi-Center, randomized, double-blind, placebo-controlled clinical trial

Tian, X., Zhou, Y., Deng, P., Xu, N., Liu, X., Guo, Y., Fang, A., Liu, P., Yi, Y., Yang, L., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127268 · Cited by 2

Dietary supplementation of arachidonic acid promotes humoral immunity

Feng, S., Ma, E., Na, X., Wang, Z., Tai, W., Bao, X., Wang, M., Chang, H., Wu, B., Liu, M.-Y., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00310-7 · Cited by 2

Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines

Zhang, X., Shi, H., & Ross, T. M. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00539-3 · Cited by 2

Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians

Dobrescu, A. I., Sharifan, A., Sommer, I., Neubauer-Bruckner, C., Gadinger, A., Klerings, I., Nowak, C. P., & Gartlehner, G. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-04028 · Cited by 2

Roads to advanced vaccines: influenza case study

Riese, P., & Guzmán, C. A. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12835 · Cited by 2

Influenza vaccine formulation and effectiveness

Ribaudo, A. S., & Hayney, M. S. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.08.002 · Cited by 2

Vaccine-Preventable Diseases and the Vaccines That Prevent Them

Diez, H. L., Hayward, A., & VanDerKolk, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60471-8_4 · Cited by 2

Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type

Ferdinands, J. M., & Patel, M. M. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.012 · Cited by 2

Towards better protection of older people against influenza and its complications. Polish recommendations for HD influenza vaccine

Nitsch-Osuch, A. S., Jankowski, P., Kokoszka-Paszkot, J., Kuchar, E. P., Mastalerz–Migas, A., Mitkowski, P. P., Wysocki, J., Zmysłowska, A., & Antczak, A. J. (2024) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2024.134715 · Cited by 2

Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain

Pérez-Rubio, A., Mestre‐Ferrandiz, J., López-Belmonte, J. L., Diaz-Aguiló, A., Lorenzo‐Herrero, S., & Crespo, C. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09637-x · Cited by 2

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Huang, P., Nowalk, M. P., Zimmerman, R. K., Olson, S. M., Talbot, H. K., Zhu, Y., Gaglani, M., Murthy, K., Monto, A. S., Martin, E. T., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2457205 · Cited by 2

Interleukin 8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in Older Adults

Quach, H. Q., Goergen, K. M., Grill, D. E., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf148 · Cited by 2

COVID-19 vaccination atlas using an integrative systems vaccinology approach

Prates-Syed, W. A., Fonseca, D. L. M., Pour, S. Z., Lira, A. A. D. L., Côrtes, N., Silva, J. D. Q., Carvalho, E., Filgueiras, I. S., Vinces, T. G. C., Schimke, L. F., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01148-3 · Cited by 2

Vaccine Development in Special Populations

Edwards, K. M., & Creech, C. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802302-0.00007-8 · Cited by 2

Influenza epidemics

Wautlet, A. J., Patel, P., Chávez, P., & Codispoti, C. D. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.11.012 · Cited by 2

Immunosenescence Modulation by Vaccination

McElhaney, J. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_71 · Cited by 2

Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

Dehghani, P., Srivatsav, V., Vardeny, O., Grewal, J., Opotowsky, A. R., Muhll, I. V., Keir, M., Ducas, R., Singh, J., Kim, K., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100897 · Cited by 2

Influenza Vaccines—Are They Efficacious or Not?

Wang, B., & Loeb, M. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55435-0.00006-9 · Cited by 2

Controlling Triggers for Asthma in Older Adults: Environmental Allergens, Indoor and Outdoor Air Pollutants, and Infection

Shams, M. R., & Epstein, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-20554-6_11 · Cited by 2

Novel Technologies to Improve Vaccines for Older Adults

Laupèze, B., der Most, R. G. V., & Giudice, G. D. (2020) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000504485 · Cited by 2

Infections virales respiratoires (hors COVID-19)

Bessis, S. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(20)30778-2 · Cited by 2

Providing Additional “Muscle” for Older Adults Through Optimal Influenza Vaccine Selection

Dougherty, J. A., & Chahine, E. B. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018772579 · Cited by 2

Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand

Praphasiri, P., Prasert, K., Shrestha, M., Ditsungnoen, D., Chittaganpitch, M., Chawalchitiporn, S., Dawood, F. S., Sirilak, S., & Mott, J. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279962 · Cited by 1

Influenza Vaccination in Solid Organ Transplant Recipients: Methods to Improve Immunogenicity and Future Directions

Peak, E., MD, Thomas, L. D., & MD (2024) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-024-00270-5 · Cited by 1

Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study

Ge, Y., Handel, A., Giabbanelli, P. J., Lemacks, J. L., Greer, T. F., Raynee, P., Bahl, J., Skarlupka, A. L., Dobbin, K. K., Ross, T. M., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126802 · Cited by 1

Relative vaccine effectiveness of high-dose vs. standard-dose influenza vaccine against clinical outcomes according to history of atrial fibrillation: a pre-specified analysis of the DANFLU-1 randomized trial

Espersen, C., Johansen, N. D., Modin, D., Janstrup, K. H., Loiacono, M. M., Harris, R. C., & Biering‐Sørensen, T. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf102 · Cited by 1

Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial

Duus, L. S., Johansen, N. D., Modin, D., Janstrup, K. H., Nealon, J., Samson, S., Loiacono, M. M., Harris, R. C., Larsen, C. S., Jensen, A. M. R., et al. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.10.016 · Cited by 1

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial

Bernholm, K. F., Johansen, N. D., Espersen, C., Modin, D., Janstrup, K. H., Nealon, J., Samson, S., Loiacono, M. M., Harris, R. C., Larsen, C. S., et al. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05408-5 · Cited by 1

Vaccination for Older Adults in India: Position Statement of the Indian Academy of Geriatrics

Singhal, S., Dewangan, G. C., Mehta, P. K., Viggeswarpu, S., Dey, A. B., & Gunasekaran, V. (2026) · Journal of The Indian Academy of Geriatrics · doi:10.4103/jiag.jiag_42_26 · Cited by 1

Influenza Vaccination as Cardiovascular Prevention in Adults with Heart Disease

Bonanad, C., Barrios, V., Barreres-Martín, G., Maidana, D., & Redondo, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145343 · Cited by 1

High-dose influenza vaccines in older adults: benefits and gaps

Icardi, G., & Paolozzi, V. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2026.100886 · Cited by 1

Les vaccins dans la prévention des infections associées aux soins

Gagneux‐Brunon, A., Lucht, F., Launay, O., Berthelot, P., & Botelho-Nevers, É. (2017) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2017.05.001 · Cited by 1

Severe Respiratory Viral Infections: Epigenetic Mechanisms of Predisposition and the Possibilities of Epigenetically Targeted Therapy

Айтбаев, К. А., Murkamilov, I. T., Fomin, V. V., Абдилалимовна, М. Ж., & Yusupov, F. A. (2021) · Bulletin of Science and Practice · doi:10.33619/2414-2948/64/13 · Cited by 1

Influenza Viruses

Treanor, J. J. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_19-1 · Cited by 1

Survival at older ages: Are greater influenza antibody titers protective?

Metcalf, C. J. E., Klein, S. L., Read, J. M., Riley, S., Cummings, D. A. T., Guan, Y., Kwok, K. O., Zhu, H., Jiang, C., Lam, T. H., et al. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111135 · Cited by 1

Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain

Pérez-Rubio, A., Flores, R., Ruiz-Aragón, J., Sanchez, J., Márquez-Peláez, S., Alvarez, P., Muriel, A. O., & Mould-Quevedo, J. F. (2025) · Vaccines · doi:10.3390/vaccines13030323 · Cited by 1

A Bayesian re-analysis of the DANFLU-1 trial

Modin, D., Johansen, N. D., Granholm, A., Claggett, B. L., Nealon, J., Samson, S., Loiacono, M. M., Harris, R. C., Larsen, C. S., Jensen, A. M. R., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2550050 · Cited by 1

Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product Recommendations

Belongia, E. A., Nguyen, H. Q., McClure, D. L., Lewis, N. M., Ellington, S., Flannery, B. L., & Petrie, J. G. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf563 · Cited by 1

Hypersensitivity reactions to vaccines and immunization in patients with asthma: joint recommendations of the Brazilian Association of Allergy and Immunology and the Brazilian Immunization Society

Marinho, A. K. B. B., Valente, C. F. C., Goudoris, E. S., Grumach, A. S., Fernandes, F. R., Anagusko, C. L. Y., Gerhardt, C. M. B., Casado, G. F. Z., Rondon, A. V., Silva, M. A. Á., et al. (2025) · Arquivos de Asmas Alergia e Imunologia · doi:10.5935/2526-5393.20250008 · Cited by 1

Influenza vaccination as part of cardiovascular prevention — expert opinion supported by the Working Group on Cardiovascular Pharmacotherapy and Working Group on Prevention and Epidemiology Section of the Polish Cardiac Society

Wełnicki, M. T., Kamiński, K. A., Mastalerz–Migas, A., Kuchar, E. P., Jankowski, P., Gil, R. J., Mitkowski, P. P., Mamcarz, A., & Wysocki, J. (2025) · Kardiologia Polska · doi:10.33963/v.phj.109619 · Cited by 1

Relative Effectiveness of High‐Dose vs. Standard‐Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 Season

Bricout, H., LEVANT, M.-C., Crépey, P., Gavazzi, G., Gaillat, J., Dufournet, M., Assi, N., Grenier, B., RAGUIDEAU, F., Péretz, F., et al. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70193 · Cited by 1

Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain

Abellán‐Perpiñán, J., Margüello, E. R., de Miguel, Á. G., Muñoz, I. S., Diaz-Aguiló, A., Jiménez, P. I. P., Avellà, J. M. F., Callejo, D., Pinel, M., & López-Belmonte, J. L. (2026) · The European Journal of Health Economics · doi:10.1007/s10198-026-01894-8 · Cited by 1

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09‐Associated Hospitalizations With SARI in Beijing, China, in the 2024–2025 Season

Ma, C., Sun, Y. L., Ma, J., Wang, Y., Hu, X., Shen, Y., Zhang, L., Zhang, J., Zhang, L., Duan, W., et al. (2026) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70248 · Cited by 1

Increased dose of H1N1 pandemic influenza vaccine during pregnancy improves immunity in mothers and infants

Kansara, D. N., Košíková, M., Milletich, P. L., Zhou, J., Coughlan, L., Zens, M. S., Swamy, G. K., Hoen, A. G., Xie, H., Ackerman, M. E., et al. (2026) · mBio · doi:10.1128/mbio.03904-25 · Cited by 1

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial

Loubet, P., Czernichow, S., Giboin, C., Sultan, A., Guimard, T., Disse, E., Tavolacci, M., Ghezala, I. B., Ledoux, S., Janssen, C., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag200 · Cited by 1

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses

Nguyen, T. H. O., Foo, I. J. H., Purcell, R. A., Tan, H., Deliyannis, G., Zhang, W., Carolan, L. A., Hadiprodjo, A. J., Huang, H. H., Allen, L. F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aea8621 · Cited by 1

Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence – a meeting report

Moerlooze, L. D., Allen, A., Bartalesi, I., Cavaleri, M., Davenport, M. P., Gessner, B. D., Gomes, B., Hayford, K., Izu, A., Izurieta, H. S., et al. (2026) · Biologicals · doi:10.1016/j.biologicals.2026.101886 · Cited by 1

Immunosenescence as a driver of the transition from frailty to multimorbidity

Qiu, R., Zhang, D., & Feng, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1810241 · Cited by 2

Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years

Diaz-Estevez, L., Rivera‐Izquierdo, M., Fernández‐Martínez, N. F., Ocana-Rodriguez, D., Moreno‐Pérez, D., & Lorusso, N. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.06.018 · Cited by 1

High-dose influenza vaccine in older adults

Wang, J. M., Vardeny, O., & Zorek, J. A. (2016) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2015.12.001 · Cited by 1

Reinvigorating Influenza Prevention in US Adults Aged 65 Years and Older

Schaffner, W., Gravenstein, S., HOPKINS, R. H., & Jernigan, D. B. (2016) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000462 · Cited by 1

Immunizations for adult women

Faubion, S. S., & Larkin, L. C. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000781 · Cited by 1

Influenza Vaccines for Older Persons: Progress and Pitfalls

Neuzil, K. M., & Chen, W. H. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix285 · Cited by 1

Vaccines for adults: a review of recent literature

Ahmed, M., Alorinan, B., AlYemni, A., Albakri, M., Alahmari, M., Hassan, A., Alrahili, A. S., Alfawzan, A., Alazzouni, A., & Alansari, A. (2018) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20184601 · Cited by 1

Acquired immune responses to the seasonal trivalent influenza vaccination in COPD

Staples, K. J., Williams, N. P., Bonduelle, O., Hutton, A. J., Cellura, D., Marriott, A. C., Combadière, B., & Wilkinson, T. M. A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13336 · Cited by 1

Influenza – jeder kennt die „Grippe“ und doch wird sie immer noch unterschätzt

Welte, T. (2019) · Der Pneumologe · doi:10.1007/s10405-019-0257-3 · Cited by 1

Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins »

Autran, B., Combadière, B., Launay, O., Grand, R. L., Locht, C., Tangy, F., Verger, P., & Garçon, N. (2017) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30502-3 · Cited by 1

Immunopathogenesis, Immunization, and Treatment of Infectious Diseases

Szollosi, D. E., Mathias, C. B., Lucero, V., Ahmad, S. I., & Donato, J. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-19922-7_9 · Cited by 1

Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines

Damjanovska, S., Smith, C., Sayın, I., Burant, C. J., Gravenstein, S., & Canaday, D. H. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.12.051 · Cited by 1

Prevention and screening

Birch, J. T., & Bhattacharya, S. B. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.004 · Cited by 1

Vaccin grippal haute dose : un vaccin adapté aux 65 ans et plus

Gavazzi, G., Mosnier, A., Crépey, P., & Gaillat, J. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.001 · Cited by 1

Immunosenescence Modulation by Vaccination

McElhaney, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_71-1 · Cited by 1

Using re-randomisation designs to increase the efficiency and applicability of retention studies within trials: a case study

Goulão, B., Duncan, A., Innes, K., Ramsay, C. R., & Kahan, B. C. (2023) · Trials · doi:10.1186/s13063-023-07323-y · Cited by 1

Similar humoral responses but distinct CD4+ T cell transcriptomic profiles in older adults elicited by MF59 adjuvanted and high dose influenza vaccines

Quach, H. Q., Haralambieva, I. H., Goergen, K. M., Grill, D. E., Chen, J., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-75250-2 · Cited by 1

The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina

Urueña, A., Micone, P., Mould-Quevedo, J. F., Saenz, C., Delgado, M., Montes, J. L., & Giglio, N. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100587 · Cited by 2

Enhancing Influenza Vaccination for Adults Aged 50–64Years: Addressing Moderate Vaccine Efficacy

Davido, B., & Kharkhordine, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf070 · Cited by 1

Antiviral CD4+ T and myeloid cell responses to influenza vaccines are attenuated in older adults

Oakes, J. M., Simmons, J., Nochowicz, C. H., Kirk, L. A., Eason, J., Halasa, N., Talbot, H. K., Bailin, S. S., Castilho, J. L., & Kalams, S. A. (2026) · Communications Medicine · doi:10.1038/s43856-026-01586-7 · Cited by 1

Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland

Kondratiuk, K., Masny, A., Poznańska, A., Szymański, K., Łuniewska, K., Czajkowska, E., Mańkowski, B., & Brydak, L. B. (2025) · Biomolecules · doi:10.3390/biom15070977 · Cited by 1

Engineering mucosal immunity: Advanced vaccine platforms against respiratory pathogens

Wang, M., Chang, Q., Li, B., Yang, R., Chen, X., Bai, Y., He, H., & Zheng, B. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100040 · Cited by 3

Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age

DiazGranados, C. A., Saway, W., Gouaux, J., Baron, M., Baker, J. P., Denis, M., Jordanov, E., Landolfi, V. A., & Yau, E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.131 · Cited by 22

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19

Balasubramani, G. K., Choi, W. S., Nowalk, M. P., Zimmerman, R. K., Monto, A. S., Martin, E. T., Belongia, E. A., McLean, H. Q., Gaglani, M., Murthy, K., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.011 · Cited by 23

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season

DiazGranados, C. A., Dunning, A. J., Jordanov, E., Landolfi, V. A., Denis, M., & Talbot, H. K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.013 · Cited by 123

High-dose trivalent influenza vaccine. Efficacy and effectiveness

de Miguel, Á. G., Margüello, E. R., Díez‐Domingo, J., de Lejarazu, R. O., Martinón‐Torres, F., & Departamento de Medicina Preventiva y Salud Pública, U. R. J. C. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/043.2020 · Cited by 6